Index of reports
> Cases with Neutropenic Sepsis (21)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vinorelbine where reactions include neutropenic sepsis. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Vinorelbine side effects in 57 year old male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-10
Patient: 57 year old male
Reactions: Wrong Technique in Drug Usage Process, Neutropenic Sepsis, Skin Tightness, Incorrect Drug Administration Duration, Infusion Site Pain, Infusion Site Pruritus, Infusion Site Vesicles, Infusion Site Erythema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vinorelbine
Other drugs received by patient: Cisplatin
Possible Vinorelbine side effects in 75 year old female
Reported by a physician from United Kingdom on 2012-06-04
Patient: 75 year old female
Reactions: Haemoglobin Decreased, Haematocrit Decreased, Drug Ineffective, RED Blood Cell Count Decreased, Neutropenic Sepsis, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 7300 mg;;iv
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Rituximab (Rituximab)
Dosage: 650 mg;; iv
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Neulasta
Dosage: 6 mg; ; sc
Indication: Prophylaxis
Start date: 2011-06-15
Vinorelbine
Dosage: 2 mg;;iv
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Doxorubicin HCL
Dosage: 85 mg; ; iv
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Vincristine
Dosage: 2 mg; iv;
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Possible Vinorelbine side effects in 75 year old female
Reported by a physician from United Kingdom on 2012-05-17
Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Neutropenic Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 85 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Neulasta
Dosage: 6 mg, unk
Indication: Prophylaxis
Start date: 2011-06-15
Vinorelbine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Rituximab
Dosage: 650 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Cyclophosphamide
Dosage: 7300 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Possible Vinorelbine side effects in 75 year old female
Reported by a physician from United Kingdom on 2012-04-26
Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Neutropenic Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 85 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Neulasta
Dosage: 6 mg, unk
Indication: Prophylaxis
Start date: 2011-06-15
Cyclophosphamide
Dosage: 7300 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Vinorelbine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Rituximab
Dosage: 650 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Possible Vinorelbine side effects in 65 year old female
Reported by a pharmacist from United Kingdom on 2012-04-26
Patient: 65 year old female
Reactions: Neutropenic Sepsis, Pancytopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: unk
Indication: Lung Squamous Cell Carcinoma Stage Unspecified
Vinorelbine
Dosage: unk
Administration route: Oral
Indication: Lung Squamous Cell Carcinoma Stage Unspecified
Other drugs received by patient: Domperidone
Possible Vinorelbine side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-04-26
Patient: 65 year old female
Reactions: Neutropenic Sepsis, Pancytopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: ;iv
Indication: Squamous Cell Carcinoma
Vinorelbine
Dosage: ;po
Administration route: Oral
Indication: Squamous Cell Carcinoma
Other drugs received by patient: Domperidone
Possible Vinorelbine side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-24
Patient: 65 year old female
Reactions: Neutropenic Sepsis, Pancytopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: week 1, cycle 2, intravenous (not otherwise specified)
Indication: Lung Squamous Cell Carcinoma Stage Unspecified
Vinorelbine
Dosage: week 2, week 3 off, oral
Administration route: Oral
Indication: Lung Squamous Cell Carcinoma Stage Unspecified
Other drugs received by patient: Domperidone
Possible Vinorelbine side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-20
Patient: 65 year old female
Reactions: Neutropenic Sepsis, Pancytopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vinorelbine
Administration route: Oral
Carboplatin
Dosage: unk
Indication: Lung Squamous Cell Carcinoma Stage Unspecified
Other drugs received by patient: Domperidone
Possible Vinorelbine side effects in 75 year old female
Reported by a consumer/non-health professional from United Kingdom on 2012-04-18
Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Neutropenic Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vinorelbine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-06
Neulasta
Indication: Prophylaxis
Start date: 2011-06-15
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Possible Vinorelbine side effects in 75 year old female
Reported by a physician from United Kingdom on 2012-04-18
Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Neutropenic Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 85 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Cyclophosphamide
Dosage: 7300 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Rituximab
Dosage: 650 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Vinorelbine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-06
Neulasta
Dosage: 6 mg, unk
Indication: Prophylaxis
Start date: 2011-06-15
Possible Vinorelbine side effects in 75 year old female
Reported by a physician from United Kingdom on 2012-04-13
Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Neutropenic Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 7300 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Vinorelbine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Doxorubicin HCL
Dosage: 85 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Rituximab
Dosage: 650 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Neulasta
Dosage: 6 mg, unk
Indication: Prophylaxis
Start date: 2011-06-15
Possible Vinorelbine side effects in 75 year old female
Reported by a physician from United Kingdom on 2012-03-28
Patient: 75 year old female
Reactions: White Blood Cell Count Decreased, Monocyte Count Decreased, Band Neutrophil Count Increased, Drug Ineffective, Neutropenic Sepsis, Monocyte Count Increased, Haemoglobin Decreased, Haematocrit Decreased, RED Blood Cell Count Decreased, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 85 mg; iv
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Cyclophosphamide
Dosage: 7300 mg; iv
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-23
End date: 2011-06-09
Vinorelbine
Dosage: 2 mg; iv
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Neulasta
Dosage: 6 mg; sc
Indication: Prophylaxis
Start date: 2011-06-15
Rituximab (Rituximab)
Dosage: 650 mg; iv
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Possible Vinorelbine side effects in 75 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-26
Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Neutropenic Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 85 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Cyclophosphamide
Dosage: 7300 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Rituximab
Dosage: 650 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Vinorelbine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Other drugs received by patient: Neulasta
Possible Vinorelbine side effects in 71 year old female
Reported by a physician from United Kingdom on 2012-03-22
Patient: 71 year old female
Reactions: Klebsiella Infection, Pneumonia, Interstitial Lung Disease, Neutropenic Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Vinorelbine
Indication: Adenocarcinoma
Start date: 2009-09-01
End date: 2009-10-01
Cisplatin
Indication: Adenocarcinoma
Start date: 2009-09-01
End date: 2009-10-01
Possible Vinorelbine side effects in female
Reported by a physician from United Kingdom on 2012-03-22
Patient: female
Reactions: Neutropenic Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: code not broken
Indication: Breast Cancer Metastatic
Start date: 2011-12-15
Blinded NO Treatment Received
Dosage: code not broken
Indication: Breast Cancer Metastatic
Start date: 2011-12-15
Vinorelbine
Dosage: unk
Indication: Breast Cancer Metastatic
Start date: 2011-12-15
End date: 2011-12-29
Placebo
Dosage: code not broken
Indication: Breast Cancer Metastatic
Start date: 2011-12-15
Comparator Trastuzumab
Dosage: unk
Indication: Breast Cancer Metastatic
Start date: 2011-12-15
Diclofenac Sodium
Indication: Pain
Vinorelbine
Dosage: unk
Start date: 2012-01-04
Possible Vinorelbine side effects in 75 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-19
Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Neutropenic Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 85 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Cyclophosphamide
Dosage: 7300 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Rituximab
Dosage: 650 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Vinorelbine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Other drugs received by patient: Neulasta
Possible Vinorelbine side effects in 75 year old female
Reported by a physician from Denmark on 2012-03-19
Patient: 75 year old female
Reactions: White Blood Cell Count Decreased, Monocyte Count Decreased, Band Neutrophil Count Increased, Drug Ineffective, Neutropenic Sepsis, Haemoglobin Decreased, Haematocrit Decreased, RED Blood Cell Count Decreased, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 7300 mg, iv
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Neulasta
Dosage: 6 mg, sc
Indication: Prophylaxis
Start date: 2011-06-15
Rituximab (Rituximab)
Dosage: 650 mg, iv
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Doxorubicin HCL
Dosage: 85 mg, iv
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Vinorelbine
Dosage: 2 mg,
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Possible Vinorelbine side effects in 75 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-13
Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Neutropenic Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vinorelbine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Doxorubicin HCL
Dosage: 85 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Cyclophosphamide
Dosage: 7300 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Rituximab
Dosage: 650 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Other drugs received by patient: Neulasta
Possible Vinorelbine side effects in 71 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-13
Patient: 71 year old female
Reactions: Dyspnoea, Pneumonia Klebsiella, Interstitial Lung Disease, Neutropenic Sepsis, Cough
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: unk
Indication: Adenocarcinoma
Start date: 2009-09-01
End date: 2009-10-01
Vinorelbine
Dosage: unk
Indication: Adenocarcinoma
Start date: 2009-09-01
End date: 2009-10-01
Possible Vinorelbine side effects in 75 year old female
Reported by a physician from United Kingdom on 2012-03-05
Patient: 75 year old female
Reactions: White Blood Cell Count Decreased, Haemoglobin Decreased, Haematocrit Decreased, RED Blood Cell Count Decreased, Drug Ineffective, Neutropenic Sepsis, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin Hydrochloride
Dosage: 85 mg;iv
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Vinorelbine
Dosage: 2 mg;iv
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Rituximab (Rituximab)
Dosage: 650 mg;iv
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Neulasta
Dosage: 6 mg;sc
Indication: Prophylaxis
Start date: 2011-06-15
Cyclophosphamide
Dosage: 7300 mg;iv
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Possible Vinorelbine side effects in 75 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-29
Patient: 75 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Drug Ineffective, Neutropenic Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 7300 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Doxorubicin HCL
Dosage: 85 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Vinorelbine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
Neulasta
Dosage: 6 mg, unk
Indication: Prophylaxis
Start date: 2011-06-15
Rituximab
Dosage: 650 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-05-24
End date: 2011-06-09
|